Seven-year-old Harmony from Sheffield is supporting The Children’s Hospital Charity by taking part in Theo’s Pyjama Day in ...

“My son’s lips, at this point, started to turn blue. He also had a febrile seizure, which is why his body was stiff and ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

COVID-19 was associated with more severe disease outcomes than influenza or RSV during the 2022 to 2023 season.

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

Those most at risk from RSV include babies under 6 months old, young children who were born prematurely, and adults over 75-years-old ...

Outlook on RSV, COVID-19 and flu in Canada: Rates of respiratory syncytial virus, or RSV, and COVID-19 are decreasing nationally. The positivity rate for RSV was 8 per cent and COVID-19 was 5.9 ...